Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects.
Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects.
复制标题
DOI:
10.1007/s40262-017-0576-7
复制
发表时间:
2018-05
影响因子:
4.5
通讯作者:
Edginton AN
中科院分区:
文献类型:
--
作者:
Maharaj AR;Gonzalez D;Cohen-Wolkowiez M;Hornik CP;Edginton AN
Differences in plasma protein concentrations observed between children and adults can alter the extent of xenobiotic binding in plasma, resulting in divergent patterns of exposure. This study serves to quantify the ontogeny of α-1-acid glycoprotein (AAG) in both healthy and infected subjects. Data pertaining to AAG from healthy subjects were compiled over 26 different publications. For subjects diagnosed or suspected of infection, AAG concentrations were obtained from 214 individuals acquired over 3 clinical investigations. The analysis evaluated use of linear, power, exponential, log-linear, and sigmoid Emax models to describe the ontogeny of AAG. Utility of the derived ontogeny equation for estimation of pediatric fraction unbound (fu) was evaluated using average-fold error (AFE) and absolute average-fold error (AAFE) as measures of bias and precision, respectively. A comparison to fu estimates derived using a previously proposed linear equation was also instituted. The sigmoid Emax model provided the comparatively best depiction of AAG ontogeny in both healthy and infected subjects. Despite median AAG concentrations in infected subjects being more than 2-fold greater than those observed in healthy subjects, a similar ontogeny pattern was observed when concentrations were normalized toward adult levels. For estimation of pediatric fu, the AAG ontogeny equation derived from this work (AFE 0.99; AAFE 1.24) provided a superior predictive performance in comparison to the previous equation (AFE 0.74; AAFE 1.45). The current investigation depicts a proficient modality for estimation of protein binding in pediatrics and will, therefore, aid in reducing uncertainty associated with pediatric pharmacokinetic predictions.
登录
查看更多内容
影响因子:
6.7
作者:
Ballou, SP;Lozanski, GB;Kushner, I
通讯作者:
Kushner, I
影响因子:
2.9
作者:
Johnson, JA;Livingston, TN
通讯作者:
Livingston, TN
影响因子:
10.4
作者:
Edginton AN;Ritter L
通讯作者:
Ritter L
影响因子:
2.9
作者:
KISHINO, S;NOMURA, A;MIYAZAKI, K
通讯作者:
MIYAZAKI, K
DOI:
10.1111/j.1365-2125.1984.tb02567.x
发表时间:
1984-01-01
影响因子:
3.4
作者:
BENEDEK, IH;BLOUIN, RA;MCNAMARA, PJ
通讯作者:
MCNAMARA, PJ